Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Sep 22, 2021)
Date Submitted: Sep 12, 2021
Open Peer Review Period: Sep 12, 2021 - Sep 22, 2021
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A Comparative examination of measurement-based psychiatric care delivered via specialized telemedicine platform versus treatment as usual: A retrospective analysis
ABSTRACT
Objective:
Over 20% of US adults live with a mental illness, and the more prevalent conditions of depression and anxiety are typically managed in primary care settings rather than specialty care. The aim of this study is to determine the efficacy of a novel, measurement-driven psychiatric treatment platform delivered via an online platform (Brightside) as compared to treatment as usual (TAU).
Methods:
The TAU dataset and the Brightside dataset were constructed from the total populations of adult patients receiving care for depression from January 2018 through December 2020 (November 2018 through March 2021 for the Brightside group). Patients in both groups had a primary mental health diagnosis of depression and/or anxiety, and presence of a positive screen for depression or anxiety as measured by the PHQ-9 upon initiation of treatment. HITLAB, an independent digital health verification and testing lab, conducted comparative analyses of the two groups using chi square test of independence.
Results:
Close to 80% of Brightside patients experienced a 5 or more points reduction in their baseline PHQ9 score as compared to 52% of TAU patients. The mean reduction in PHQ9 score was slightly higher in the Brightside group (-11.5) versus the TAU group (-10.1). Chi-square tests of independence x2 (1, N=6281) = 256.75, p<=0.001 for meaningful reduction and for remission (x2 (1, N=6281) = 105.50 p<=0.001 are highly significant. Conclusion: Brightside performed significantly better than psychiatric treatment as usual in reducing symptoms of depression and anxiety in adults.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.